Roche and Shape Therapeutics sign USD 3 Bn gene therapy development deal
Key Insights and Signals – Hospital & Healthcare
Centre setup and Expansion Aspen Dental expands into the Miami market with two new offices The company has a significant footprint across the state with more than 100 offices, and its entry into the Miami market points to the company’s continued growth across the region. The offices will provide a full range of dental services while creating new jobs in the Miami area and improve access to quality oral healthcare. Read More>> Cone Health plans to open Greensboro facility in early 2022 In addition to being Cone Health’s second free-standing emergency department, the Greensboro facility will be home to a variety of unique health and wellness services. The USD 97 Mn project is a 160,000-sq. ft facility located at Drawbridge Parkway. Read More>> Prisma Health begins the USD 13 Mn expansion in Seneca The expansion will almost double the space available to treat patients from 8,400-sq. ft to 21,500-sq. ft. The work will be completed by 2023 and will include 25 new individual treatment rooms, advanced equipment, and more space for doctors and nurses. Read More>>Deal and Deal Renewal Life Healthcare enters a strategic investment deal with Quro Medical Quro Medical, a digital health startup, with Life Healthcare aims to bolster its mission by leveraging technology for people in need of home-based care. Quro Medical’s data-driven clinical interventions create good outcomes for patients while delivering more than traditional telehealth. Read More>>Partnerships Mayo Clinic, Verily partner to develop clinical decision support solutions The partnership will initially focus on a set of cardiovascular and cardiometabolic conditions, with the aim to guide clinicians toward the highest-quality care. Verily will apply advanced clinical analytics and user-centered design with the help of Mayo to deliver healthcare insights that are integrated into the provider workflow. Read More>> Geisinger and PayZen partner on AI-based medical billing app Through the billing tool, patients can schedule payments on various timelines, either on a monthly basis or in a lump sum. Unpaid healthcare bills are one of the largest sources of debt for Americans and reached USD 140 Bn last year, nearly double the amount previously thought. Read More>>Executive Movement David Ottati named President and CEO for Advent Health’s West Florida Division Ottati began his career at AdventHealth as a management resident and quickly advanced in the organization, serving in various leadership roles. Ottati will transition into his new role over the next several months, succeeding Mike Schultz. Read More>> Portea Medical appoints Meena Ganesh as Chairperson and Vaibhav Tewari as CEO In her new capacity, Ganesh will be building strategy, M&A, driving advocacy, and relationships with stakeholders such as institutional partners, government bodies, investors, and external communication. Tewari will be working on company growth, strategy roll-out, building business, and deploying technologies. Read More>>Mergers and Acquisitions Connect America acquires RPM provider 100Plus The pairing of the two companies joins Connect America’s Personal Emergency Response Services (PERS) with 100Plus’ robust and proven Remote Patient Monitoring solutions onto one care management platform. Connect America is adding complimentary digital health products to enable passive monitoring of patients in the home and better patient engagement outside of the physician’s office. Read More>> K Health acquires Mental Health App Trusst for on-demand text-based therapy With this acquisition, K Health will be expanding its mental health offerings. Users will be able to chat with clinicians 24/7 for therapy and medication at home without the need for insurance or an appointment. The financial terms of the deal were not disclosed. Read More>> GuideWell to acquire Triple-S Management in a USD 900 Mn cash deal Under the deal terms, GuideWell will acquire all Triple-S Management stock for USD 36.00 per share in cash. The transaction’s equity value is approximately USD 900 Mn. The deal is expected to close in the first half of 2022, subject to satisfactory closing conditions, including customary state and federal regulatory review and approval as well as support by Triple-S Management shareholders. Read More>>
Key Insights and Signals in Pharmaceuticals
Centre Setup and Expansion Bayer Health eyes rising rural India for growth The company hopes to grow the share of rural markets to its consumer health business’ turnover to about 25 percent from the current 7 percent in the next 4-5 years. The company aims to triple its household penetration to about 100 million households over the next five years in India. Read More>> Lonza invests in a new manufacturing site in Guangzhou, China The company is adding a new fill-finish line at the biologics manufacturing facility, which opened in the second quarter of this year. The facility can produce drugs for clinical and commercial supply with drug substance and product manufacturing capability. Read More>>Deal and Deal Renewal Eagle Pharmaceuticals enters a licensing agreement for Pneumonia treatment The company has entered into a worldwide licensing agreement with Combioxin SA for the commercial rights to CAL02. Under the agreement, Eagle will be solely responsible for further clinical development of CAL02 and will make an upfront payment to Combioxin followed by additional payments upon achievement of milestones, regulatory approval, and commercial sales. Read More>> Roche and Shape Therapeutics enter a USD 3 Bn deal to target AD and Parkinson’s The partnership will attempt to harness the RNA editing platform to take on these diseases, as well as others. Roche will apply RNAfix and Shape’s AAVid technology platform to develop next-generation tissue-specific adeno-associated viruses for new gene therapies aimed at these indications. Read More>>Partnerships Roche and BHP collaborate to improve IBD treatment Roche and BHP will investigate promising biomarkers and inflammatory mechanisms in the search for new treatment targets for Inflammatory Bowel Disease (IBD). Recently diagnosed IBD patients will be seen weekly at new clinics across sister UHB sites Queen Elizabeth Hospital Birmingham and Heartlands Hospital. Read More>> Schott forms a partnership with Serum Institute of India With this acquisition, Serum intends to secure its supply of pharma packaging amid rising global demand. SII has bought a 50% stake in Schott Kaisha, and the joint venture will continue to supply its customers in India and abroad. Read More>> Optellum, Johnson & Johnson collaborate on AI-Powered Lung-Health initiative As part of the collaboration, Optellum will provide its AI-powered clinical decision support platform to increase lung cancer survival rates through early intervention and prevention. Read More>>Mergers and Acquisition Azurity to acquire and merge with Arbor Pharmaceuticals Following the completion of the transaction, which is subject to regulatory approvals, Azurity and Arbor will merge. The combined company will have a portfolio of products serving the unmet needs of patients in the cardiovascular, central nervous system, endocrinological, gastrointestinal, and institutional markets. Read More>> Pfizer to buy cancer drug developer Trillium in USD 2.3 Bn deal The company acquired a USD 25 Mn stake in Trillium last year and will buy the remaining outstanding shares for USD 18.50 apiece. Pfizer expects to benefit from Canada-based Trillium’s blood-cancer therapies that target a unique signal used by cancer cells to evade the immune system. Read More>> Sun Pharma announces sale of Kayaku Co. Ltd The company announced the sale of Kayaku Co. Ltd, a wholly-owned subsidiary of Sun Pharma Japan Limited. Sun Pharma Japan sold its entire shareholding in Kayaku Co. Ltd. to Shinshin Pharmaceutical in September 2021. Read More>>Executive Movement Pfizer announces a new Chief Business Innovation Officer Aamir Malik has joined the company as Executive VP and Chief Business Innovation Officer. Mr. Malik will be a Pfizer’s Executive Leadership team member, reporting to Chairman and CEO Albert Bourla. Previously, he led the firm’s Global Pharmaceuticals & Medical Products practice. Read More>> Teva Pharma appoints former Moderna CMO Tal Zaks to the Board The appointment comes into effect from October 1, 2021, until the next annual general shareholders meeting in 2022. After six years in the position, Zaks is stepping down as Chief Medical Officer of vaccine developer and manufacturer Moderna Inc. and will continue to serve as a special advisor to Moderna CEO until the end of September. Read More>>
Key Insights and Signals in MedTech
Deal and Deal Renewal Encision signs supply agreement with J&J’s Auris Health Through the agreement, Auris Health will buy Active Electrode Monitoring technology from Encision. Encision will receive an upfront payment and a milestone payment upon the achievement of certain milestones. The company will also receive revenues from proprietary product sales. Read More>> Thermo Fisher gets a USD 192.5 Mn US contract to boost lab device production The company will use the award to build a new manufacturing facility in North Carolina to expand the production of pipette tips used to transfer liquids in diagnostic labs. It expects manufacturing to begin at the facility as early as the third quarter of 2023. Read More>>Partnerships AstraZeneca and Thermo Fisher partner to match Patients to Precision Therapies The partnership will leverage Thermo Fisher’s technology and expertise to inform AstraZeneca’s extensive portfolio of targeted medicines. Targeted precision therapies make up more than 90% of AstraZeneca’s pipeline across its primary focus areas, including oncology, cardiovascular, metabolic, and respiratory disease. Read More>> SKIMS and MEDTRONIC open surgical skills lab in Srinagar The Skill Lab has been developed to aid surgeons in overcoming the challenging learning curve to obtain laparoscopic expertise. The partnership will focus on providing training, replicating real-world environments, using state-of-the-art technology and teaching methods to enhance their skills, and quickly adopt the minimally invasive way of surgery. Read More>>Executive Movement Dave Crawford joins Bioventus as VP, Investor Relations, and Treasurer Crawford has more than 20 years of experience across multiple areas of finance and comes to Bioventus from Avanos Medical. Previously, Crawford spent several years in finance and treasury roles with Kimberly-Clark Corporation and was later promoted to CFO of the company’s Global Healthcare Division. Read More>> Erania Brackett appointed as CMO at Dentsply Sirona Brackett will be responsible for developing the business plan to elevate the brand while building a more comprehensive global online presence. She brings more than 20 years of experience to the Charlotte-based company, which is the world’s largest manufacturer of dental products and technologies, bringing in USD 3.3 Bn in revenue last year. Read More>> NuVasive announces new Executive Leadership Roles Massimo Calafiore has been appointed as Chief Commercial Officer, and Ryan Donahoe has been appointed Chief Technology Officer, both reporting directly to Chief Executive Officer J. Christopher Barry. This new structure puts in place leaders who have decades of spine and orthopedics experience to advance NuVasive’s short-term and long-term strategies. Read More>> Mika Nishimura joins the Board of Accuray Mika’s background makes her an ideal candidate for the Accuray’s Board as the company continues to introduce new innovative technology to drive its strategic growth. She is an experienced medical device executive who has a track record of value creation in both management and governance roles. Read More>>Mergers and Acquisition Bioventus invests in Trice Medical, an orthopedics company Bioventus led the deal, including the acquisition of exclusive sales and distribution rights to Trice Medical products outside of the United States. Additionally, the companies agreed to enter into a co-development arrangement. Read More>> Nihon Kohden set to acquire AMP3D to advance analytics The AMP3D CoMET analytics software can identify multiple adverse events outcomes and display these to the caregiver. Integrating AMP3D’s algorithms into patient monitoring systems will enable additional insights into the patient status and help reduce adverse events. Read More>> Nordson Corp announces agreement to acquire NDC Technologies The acquisition expands Nordson’s test and inspection platform into new end markets and adjacent technologies. The all-cash transaction, subject to customary post-closing adjustments, is valued at over USD 180 Mn. Read More>>
Latest Industry Insights from Draup Braindesk
Major players in the Healthcare sector are incorporating digital technologies to detect and diagnose conditions earlier and monitor symptoms to prevent diseases. They are actively partnering with their peers to enhance the patient-centric experience by testing technological solutions like Remote Patient Monitoring, AI-powered care, and Analytics for chronic care management.
MyDoc launched RPM@Home, a remote patient monitoring (RPM) kit poised to transform healthcare using a web-based intelligence platform to monitor patients and transmit real-time biometric data to healthcare providers.
Sana Kliniken has developed a symptom checking system built on Infermedica’s Symptom Checker. The Symptom Checker integrated into Sana’s website will provide the patient with validated medical information.
Fortis Hospitals partnered with Phable to develop AI-powered guidance and detection system to alert patients on early warning indicators.
AstraZeneca collaborated with Accent Therapeutics to discover, develop, and commercialize transformative therapeutics targeting RNA-modifying proteins for cancer treatment.
ORPEA has adopted a daily and emergency telemedicine solution for all its facilities, retirement homes, follow-on care, and psychiatric clinics.
Mayo Clinic teamed with Mymeds for enabling patient education content for medication adherence.
Key Funding Alert
Ellipsis Health lands USD 26 Mn in Series A funding
Behavioral health AI company Ellipsis Health has bagged USD 26 Mn in Series A funding. SJF Ventures led the round, with additional participation from Able Partners, Alumni Ventures, Generator Ventures, and Luminous Ventures, among other investors. The new investment brings the total amount raised by the company thus far up to USD 31 Mn. Read More>>
Startup Spotlight
Company – Felix Health Total Funding– USD 10.3 Mn About: Felix is an end-to-end platform where you can get prescriptions for lifestyle medications through an online visit with a licensed Canadian doctor and have your medication shipped to you on an automated refill schedule that works for you. Read More>>
Latest Reports Published in Draup
Blue Cross Blue Shield of Michigan Account Intelligence Report: Blue Cross Blue Shield of Michigan is focused on introducing health plans to help small and medium-size organization’s employees. The company also concentrates on introducing pharmaceuticals business segment to help the patients in drug assistance. Read More>>
Centene Corporation Account Intelligence Report:Centene Corporation focuses on the enhancement of the healthcare platform and real-time monitoring capabilities-related engagements. It also aims to offer quality drugs for patients having multifactorial and rare diseases. Read More>>
Here’s what’s new on our Sales Intelligence Platform Filter Tech Stack & Use Cases with Keyword Search
Digital Tech Stack and Use Cases filter in Universe supports keyword search
View the Certifications in Demand in the Hiring section
View the Job Type information for the job postings in the Hiring section
Sales
